PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Urological Oncology10.22465/kjuo.2021.19.3.1742021193174-182Investigation of Information Acquisition Channel for Prostate Cancer High-Risk GroupYun-Sok Ha, Kwang Taek Kim, Wook Nam, Hongzoo Park, Sangjun Yoo, Chan Ho Lee, Ho Seok Chung, Woo Suk Choi, Jiyoun Kim, Jaeeun Shin, Jeong Hyun Kim, Cheol Kwakhttp://kjuo.or.kr/upload/pdf/kjuo-19-3-174.pdf, http://kjuo.or.kr/journal/view.php?doi=10.22465/kjuo.2021.19.3.174, http://kjuo.or.kr/upload/pdf/kjuo-19-3-174.pdf
Cancer10.1002/cncr.262812011118112-14What is the best way to treat high-risk prostate cancer?Eric A. Kleinhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.26281, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26281/fullpdf
The Prostate10.1002/pros.232672016773282-290Calcium Channel Blocker Use and Risk of Prostate Cancer byTMPRSS2:ERGGene Fusion StatusMilan S. Geybels, Karen D. McCloskey, Ian G. Mills, Janet L. Stanfordhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23267, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23267, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23267/fullpdf
Science News10.1002/scin.5591681517200516815238-238Biomedicine: High testosterone linked to prostate cancer riskhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fscin.5591681517, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fscin.5591681517, http://onlinelibrary.wiley.com/wol1/doi/10.1002/scin.5591681517/fullpdf
Prostate Cancer10.1007/978-3-319-78646-9_112018157-168High-Intensity Focused Ultrasound (HIFU) Options for High-Risk Prostate CancerBruno Nahar, Vivek Venkatramani, Dipen J. Parekhhttp://link.springer.com/content/pdf/10.1007/978-3-319-78646-9_11
International Journal of Urology10.1111/iju.120692013203290-300Radical prostatectomy in high-risk prostate cancerJoseph Ischia, Martin Gleavehttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fiju.12069
Prostate Cancer10.1007/978-3-319-78646-9_102018135-156Evaluation and Treatment for High-Risk Prostate CancerLucas W. Dean, Karim A. Touijerhttp://link.springer.com/content/pdf/10.1007/978-3-319-78646-9_10
Management of Advanced Prostate Cancer10.1007/978-981-10-6943-7_5201841-49Pelvic Lymphadenectomy for High-Risk Prostate CancerChunwoo Lee, Dalsan Youhttp://link.springer.com/content/pdf/10.1007/978-981-10-6943-7_5
BJU International10.1111/j.1464-410x.2012.11624.x201211010E431-E432Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupPirus Ghadjar, George N. Thalmannhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-410X.2012.11624.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2012.11624.x/fullpdf
Clinical Genitourinary Cancer10.1016/j.clgc.2016.10.0032017154445-449Prostate Cancer in Patients With High Prostate-Specific Antigen Levels but Otherwise Very-Low-Risk Disease Behaves Like Prostate Cancer in High-Risk PatientsMatthew M. Gestaut, Jessica E. Pruszynski, Gregory P. Swansonhttps://api.elsevier.com/content/article/PII:S1558767316303123?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1558767316303123?httpAccept=text/plain